Skip to content

Cytokine Profiles in Children With Obstructive Sleep Apnea

Local and Systemic Cytokine Profiles in Children With Obstructive Sleep Apnea and Controls

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00456573
Enrollment
40
Registered
2007-04-05
Start date
2006-04-01
Completion date
2008-12-01
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Keywords

Pediatric Obstructive sleep apnea syndrome

Brief summary

The purpose of this study is to compare the cytokine profile of tonsillar and peripheral blood mononuclear cells in patients with obstructive sleep apnea (OSA) and to compare the blood mononuclear cell cytokine secretion profile between patients with obstructive sleep apnea and controls without apnea.

Detailed description

We will recruit subjects with OSA about to undergo adenotonsillectomy and collect a blood sample and portion of their tonsils after the induction of general anesthesia. The mononuclear cells will be isolated from both these tissues and stimulated with different markers and cytokines assayed and compared. We will also recruit patients with no symptoms of OSA undergoing unrelated elective surgery and ascertain the absence of OSA by having the parents fill out a sleep questionnaire. We will then collect blood samples from these patients after the induction of anesthesia and examine the cytokine secretion profile and compare it to that of the children with OSA.

Interventions

PROCEDUREtonsillectomy

medically indicated tonsillectomy in subjects with and without OAS

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Months to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* OSA documented by polysomnography and clinical symptoms. * Patients with no symptoms of OSA and negative sleep questionnaire.

Exclusion criteria

* Significant systemic disease except mild asthma

Design outcomes

Primary

MeasureTime frame
levels of cytokines released from PBMCs of OAS subjects and controlsjust prior to surgery

Secondary

MeasureTime frame
cytokine level comparison between PBMCs and tonsillar lymphocytes within OAS groupsat time of surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026